The most critical aspect of administrative support is oversight of the science in the component projects. Dr. Robertson, Principal investigator, will meet with project leaders at least monthly on an individual basis to review progress and to plan further research strategies, particularly emphasizing areas in which advances in one project may lead to the formulation of new hypotheses, or otherwise alter the conduct of studies in a different programmatic area. Dr. Robertson will be accompanied at these meetings by the PPG biostatistician. Dr. William Dupont. Biostatistical support is a critical component of any clinical study. In view of the intensity of such patient- oriented investigations in this program project grant proposal. Dr. William Dupont, of the Division of Biostatistics, has served all components of this proposal as a consultant and collaborator, functions that will continue throughout the duration of the program. Support for Dr. Dupont is therefore budgeted in this core. Investigators in this Program will be supported by the administrative services of this Core, particularly in preparation of non-competing renewals, in financial management, and in organization of the annual mini-site visits of the Advisory Committees. Several investigators in the Program devote effort to more than one Project or Core, so Other Support services, such as telephone, medical illustrations, and reprint charges as well as Travel are budgeted centrally here. The administrative core will be responsible for coordinating the office management of the PPG. Amy Shelton and Beth Berman will be supported at 15% effort. Beth has been overseeing this grant at Vanderbilt for the past year and has been the key interface with individuals in the PPG on a daily basis. She manages all administrative aspects of the grant including progress report submission. Her efficiency, cheerfulness, and attention to detail have been pivotal to the smooth operation of our PPG.
The Administrative Core provides essential support for scientific communication between Program Project Grant investigators. It provides biostatistical support to all investigators in this grant. It provides support for all administrative functions, including financial management, personnel issues, and compliance with institutional and governmental regulations.
|Mar, Philip L; Raj, Satish R (2018) Orthostatic hypotension for the cardiologist. Curr Opin Cardiol 33:66-72|
|Chaugai, Sandip; Dickson, Alyson L; Shuey, Megan M et al. (2018) Co-Prescription of Strong CYP1A2 Inhibitors and the Risk of Tizanidine-Associated Hypotension: A Retrospective Cohort Study. Clin Pharmacol Ther :|
|van den Berg, Maarten P; Almomani, Rowida; Biaggioni, Italo et al. (2018) Mutations in CYB561 Causing a Novel Orthostatic Hypotension Syndrome. Circ Res 122:846-854|
|Mai, Tu H; Garland, Emily M; Diedrich, André et al. (2017) Hepatic and renal mechanisms underlying the osmopressor response. Auton Neurosci 203:58-66|
|Kawai, V K; Levinson, R T; Adefurin, A et al. (2017) A genetic risk score that includes common type 2 diabetes risk variants is associated with gestational diabetes. Clin Endocrinol (Oxf) 87:149-155|
|Pezawas, Thomas; Diedrich, André; Robertson, David et al. (2017) Risk of arrhythmic death in ischemic heart disease: a prospective, controlled, observer-blind risk stratification over 10 years. Eur J Clin Invest 47:231-240|
|Adefurin, A; Ghimire, L V; Kohli, U et al. (2017) Genetic variation in the alpha1B-adrenergic receptor and vascular response. Pharmacogenomics J 17:366-371|
|Kaufman, Melissa R; Chang-Kit, Laura; Raj, Satish R et al. (2017) Overactive bladder and autonomic dysfunction: Lower urinary tract symptoms in females with postural tachycardia syndrome. Neurourol Urodyn 36:610-613|
|Shaw, Brett H; Garland, Emily M; Black, Bonnie K et al. (2017) Optimal diagnostic thresholds for diagnosis of orthostatic hypotension with a 'sit-to-stand test'. J Hypertens 35:1019-1025|
|Kawai, Vivian K; Levinson, Rebecca T; Adefurin, Abiodun et al. (2017) Variation in the ?2A-adrenergic receptor gene and risk of gestational diabetes. Pharmacogenomics 18:1381-1386|
Showing the most recent 10 out of 315 publications